Maria Charlotte Fribert
Directeur Général chez TOLERANZIA AB
Postes actifs de Maria Charlotte Fribert
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TOLERANZIA AB | Directeur Général | 11/04/2016 | - |
| Investor Relations Contact | 11/04/2016 | - | |
| Directeur des opérations | - | 11/04/2016 |
Historique de carrière de Maria Charlotte Fribert
Anciens postes connus de Maria Charlotte Fribert
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Epixis SA
 Epixis SA BiotechnologyHealth Technology Epixis SA is a biotechnology company that develops platform for preventive and therapeutic vaccines based on VLPs ('virus-like particles'). It manufactures seasonal or pandemic flu vaccines, to treat Hepatitis C, and to be applied to other infectious diseases, such as Human papillomavirus (HPV) or Human immunodeficiency virus (HIV). The company was incorporated in 2003 and is headquartered in Paris, Frace. | Fondateur | - | - |
| AstraZeneca R&D Mölndal | Corporate Officer/Principal | - | - |
Formation de Maria Charlotte Fribert
Statistiques
Internationale
| Suède | 3 |
| France | 3 |
Opérationnelle
| Chief Executive Officer | 1 |
| Chief Operating Officer | 1 |
| Investor Relations Contact | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TOLERANZIA AB | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Université Pierre et Marie Curie | Consumer Services |
| AstraZeneca R&D Mölndal | |
Epixis SA
Epixis SA BiotechnologyHealth Technology Epixis SA is a biotechnology company that develops platform for preventive and therapeutic vaccines based on VLPs ('virus-like particles'). It manufactures seasonal or pandemic flu vaccines, to treat Hepatitis C, and to be applied to other infectious diseases, such as Human papillomavirus (HPV) or Human immunodeficiency virus (HIV). The company was incorporated in 2003 and is headquartered in Paris, Frace. | Health Technology |
- Bourse
- Insiders
- Maria Charlotte Fribert
- Expérience
